Safety and Efficacy of Locoregional Treatment during Immunotherapy with Nivolumab for Hepatocellular Carcinoma: A Retrospective Study of 41 Interventions in 29 Patients
Brett Marinelli, Mario A. Cedillo, Sara Pasik, D. Charles, Shashi Murthy, Rahul Patel, A. Fischman, Monda Ranade, V. Bishay, S.F. Nowakowski, Max W. Sung, Thomas U. Marron, R. Lookstein, Myron Schwartz, Edward Kim
Topics & Concepts
NivolumabMedicineHepatocellular carcinomaAdverse effectRetrospective cohort studyInternal medicineResponse Evaluation Criteria in Solid TumorsLiver cancerGastroenterologyOncologySurgeryCancerImmunotherapyChemotherapyProgressive diseaseHepatocellular Carcinoma Treatment and PrognosisCholangiocarcinoma and Gallbladder Cancer StudiesHepatitis B Virus Studies